Latest AI and machine learning research in chemotherapy for healthcare professionals.
Paclitaxel (PTX) chemotherapy is constrained by an "immunomodulatory paradox," where antitumor Type I Interferon (IFN-I) activation is coupled with detrimental pro-inflammatory cascades. To address this challenge, we developed Deep Learning for Innate Immunity Modulatory Potential (DLINP), a Transformer-based framework designed to identify precision immunomodulators that uncouple IFN-I induction f...
Response assessment of primary kidney tumors in the consolidation cytoreductive and neoadjuvant settings offers a unique opportunity to inform postoperative adaptive treatment strategies. Yet, systematic analyses of nephrectomy specimens post immune checkpoint inhibition (ICI) therapies are lacking. We retrospectively identified consecutive renal cell carcinoma (RCC) patients with locoregionally a...
BACKGROUND: Optimizing adjuvant chemotherapy (AC) for gastric cancer (GC) remains challenging due to patient heterogeneity. While the lymph node ratio...
Neoantigens are tumor-specific antigens resulting from genetic, transcriptomic, and proteomic changes, making them a promising avenue for personalized...
BACKGROUND: Ovarian cancer remains the deadliest gynecological malignancy, with neoadjuvant chemotherapy (NACT) often leaving residual fibroblast-enri...
BACKGROUND & AIMS: Immunochemotherapy (IO-chemo) has become standard care for patients with unresectable intrahepatic cholangiocarcinoma (iCCA), but b...
OBJECTIVES: Preoperative prediction of perineural invasion (PNI) in rectal cancer (RC) is challenging due to limited MRI resolution and the neglect of...
Skin cytotoxicity assessment of small molecules is vital for assessing their risk of cytotoxicity upon topical contact. However, identifying cytotoxic...
OBJECTIVES: To explore the molecular mechanisms and key pharmacodynamic basis of Baishao for alleviating cancer-related fatigue (CRF) during chemother...
Neoadjuvant immunotherapy is reshaping the treatment landscape of locally advanced gastric cancer (GC). The central clinical challenge has expanded fr...
OBJECTIVES: A substantial proportion of adults with locally advanced gastric cancer derive limited benefit from neoadjuvant chemotherapy (NAC), with a...
Endoscopic diagnostics and treatment of early esophageal neoplasia have achieved considerable progress in recent years. For Barrett's esophagus-associ...
Brain cancer is one of the most challenging malignancies and a major contributor to worldwide morbidity and mortality. Glioblastoma, the most aggressi...
Alopecia areata (AA) is a common autoimmune condition that affects approximately 2% of the global population. Although it most commonly presents with ...
BACKGROUND: Immunotherapy resistance in lung adenocarcinoma (LUAD) remains a critical clinical challenge, and the mechanisms underlying resistance-ass...
The development and validation of prognostic and predictive biomarkers in breast cancer is limited by the availability of well-annotated datasets link...
BACKGROUND AND PURPOSE: Artificial intelligence (AI) algorithms have been used to synthesize standard-dose images from low-dose images in brain MRI, b...
BACKGROUND: Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Accurate early prediction of response ...
BACKGROUND: Liver enzyme biomarkers are known to contribute to the onset and progression of colorectal cancer. OBJECTIVE: To develop a novel oxidative...